MentionFox
Home › Executive changes › In8bio, Inc.
Leadership changes · INAB · SEC Form 8-K, Item 5.02

Leadership changes at In8bio, Inc. (2026)

Before you join, sell to or invest in In8bio, Inc.

MentionFox check on In8bio, Inc.: no red flags found in 3 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/executive-changes/in8bio

  • Note: Layoff plan disclosed Sep 2024 (about 19 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 19 employees) (filing, first seen 14 November 2026).

Check In8bio, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about In8bio, Inc.?

Who joined and who left In8bio, Inc. (INAB)? 1 appointment and 1 departure reported from 2026-02-09 to 2026-02-27, each cited to the company's own filing.

Kate Rochlin was named President of In8bio, Inc., effective February 4, 2026. As of November 14, 2026, In8bio, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 9, 2026 to February 27, 2026, naming 1 appointment and 1 departure (Form 8-K, February 9, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

683 Capital Management, LLC also filed stake reports on 10 other companies ↓

Sell to companies like In8bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes2
In (appointed)1
Out (departing)1
Latest filing2026-02-27

In8bio, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-09 to 2026-02-27. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as In8bio, Inc. files it.

Layoffs on record: about 19 jobs, latest 2024-09-04 (layoff filings and notices).

Also on the record for In8bio, Inc.

DateRecordFigureOur pageSource
August 13, 2026Stake report, Schedule 13G/A, by LYTTON LAURENCE W9.99% of the class5%+ stakesSource
May 29, 2026Stake report, Schedule 13D/A, by EMILY FAIRBAIRN2.2% of the class5%+ stakesSource
March 2, 2026Stake report, Schedule 13G, by LYTTON LAURENCE W9.99% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G, by Alyeska Investment Group, L.P.9.9% of the class5%+ stakesSource
January 29, 2026Stake report, Schedule 13G, by Franklin Resources, Inc.9.4% of the class5%+ stakesSource
January 2, 2026Stake report, Schedule 13D, by EMILY FAIRBAIRN7.5% of the class5%+ stakesSource
December 30, 2025Form D, private offering$20.12M soldForm D pageSource
December 30, 2025Stake report, Schedule 13G, by 683 Capital Management, LLC7.86% of the class5%+ stakesSource
December 29, 2025Stake report, Schedule 13D/A, by BIOS Fund II, LP4% of the class5%+ stakesSource
December 22, 2025Stake report, Schedule 13G, by Stonepine Capital Management, LLC9.9% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Alyeska Investment Group, L.P.2.58% of the class5%+ stakesSource
August 13, 2025Stake report, Schedule 13G/A, by Transcend Partners Opportunity Fund LLC2.6% of the class5%+ stakesSource

Selling to them or working with them? See who runs In8bio, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on In8bio, Inc. and the records around it.

In8bio, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on In8bio, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on In8bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on In8bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 14 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-27OutDirector2026-02-288-K, 2026-02-27
2026-02-09InPresident2026-02-048-K, 2026-02-09

Why did they leave? What the filings say

For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.

Who leads In8bio, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to In8bio, Inc.?

New leaders reset buying decisions — get the Full Report on In8bio, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch In8bio, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Director at In8bio, Inc., with the record behind each one.

Find candidates like Director at In8bio, Inc.

Every change, in the filing's words

Filed 2026-02-27 · 8-K

Departing: Alan S. Roemer, Director, effective 2026-02-28

On February 26, 2026, Alan S. Roemer notified the Board of Directors (the "Board") of IN8bio, Inc. (the "Company") of his decision to resign as a director of the Board and as a member of the Audit and Compensation Committees of the Board, effective as of February 28, 2026.

Also stated in this filing

  • The Board has appointed Jeremy Graff, an independent director, as Interim Chair of the Board, effective as of February 28, 2026.
Filed 2026-02-09 · 8-K

Appointed: Kate Rochlin, President, effective 2026-02-04

On February 4, 2026, the Company's Board of Directors appointed Kate Rochlin, the Company's Chief Operating Officer, as President of the Company, effective February 4, 2026.

Also stated in this filing

  • Dr. Rochlin will continue to serve as the Company's Chief Operating Officer.

Tools for this story

Each opens in a new tab, filled in for In8bio, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

More on IN8BIO, INC.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/in8bio
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
In8bio, Inc. executive departure 2026. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/in8bio